Prevalence of HPV in male-to-female transgender neovagina in KCMH

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20181104005

Enrollment

Registered

2018-11-04

Start date

2018-09-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV infection transgender neovagina anus HPV DNA cytology

Interventions

Diagnostic

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: female-to-male transgender with neovagina

Exclusion criteria

Exclusion criteria: - marked stenosis of neovagina

Design outcomes

Primary

Measure	Time frame
HPV DNA PCR from neovagina immediate positive/negative	—

Secondary

Measure	Time frame
HPV DNA PCR from anus immediate positive/negative,neovaginal cytology immediate cytology	—

Countries

Thailand

Contacts

Public ContactSutira Uaamnuichai

KCMH

sutira.uaamnuichai@gmail.com0968785434

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Prevalence of HPV in male&#45;to&#45;female transgender neovagina in KCMH